Will lenacapavir be EMA approved for HIV prevention by end of 2024? | Binary | | | 6 months ago | |
Will lenacapavir be FDA approved for HIV prevention by end of 2024? | Binary | | | 6 months ago | |
Will Gilead Sciences stock price increase by 20% or more by end of 2024? | Binary | | | 4 months ago | |
Gilead's stock price increases by 10% by Q3 2024? | Binary | | | 6 months ago | |
FDA Approval of Sunlenca by end of 2024? | Binary | | | 6 months ago | |
Sunlenca available to consumers by Q1 2025? | Binary | | | 6 months ago | |
Will Gilead's stock price increase by more than 20% by end of 2024? | Binary | | | 6 months ago | |
Will Sunlenca be FDA approved for HIV prevention by end of 2024? | Binary | | | 6 months ago | |
Will Gilead's lenacapavir receive FDA approval by December 31, 2025? | Binary | | | 10 days ago | |
Will Livdelzi receive full FDA approval by August 14, 2025? | Binary | | | 4 months ago | |
Will Sunlenca be added to WHO's List of Essential Medicines by mid-2025? | Binary | | | 6 months ago | |
Gilead to sell generic HIV prevention injections in 120 countries by June 30, 2025? | Binary | | | 22 days ago | |
Will Gilead's stock price increase by 10% or more by the end of 2024? | Binary | | | 3 months ago | |
Will Gilead's Lenacapavir receive FDA approval for HIV prevention by end of 2024? | Binary | | | 3 months ago | |
Will Gilead's stock price increase by at least 10% within one week of FDA approval of Lenacapavir? | Binary | | | 3 months ago | |
Will Livdelzi achieve $500M in sales by August 14, 2025? | Binary | | | 4 months ago | |
What will Gilead's market valuation be by August 14, 2025? | Categorical | | | 4 months ago | |
Will Gilead's stock price increase by 10% or more by September 14, 2024? | Binary | | | 4 months ago | |
Will Livdelzi achieve $500 million in sales by end of 2024? | Binary | | | 4 months ago | |
Will Gilead Sciences' adjusted EPS for Q3 2024 exceed $2.00? | Binary | | | 5 months ago | |
Will Gilead Sciences' total revenue for Q3 2024 exceed $7 billion? | Binary | | | 5 months ago | |
Will Gilead Sciences' stock price increase by at least 5% by the end of Q3 2024? | Binary | | | 5 months ago | |
What will be Gilead Sciences' adjusted EPS for full-year 2024? | Categorical | | | 5 months ago | |
What will be Gilead Sciences' Biktarvy sales for full-year 2024? | Categorical | | | 5 months ago | |
Which company will introduce a competing HIV prevention drug by end of 2024? | Categorical | | | 6 months ago | |
Sunlenca vs. Truvada market share by end of 2025? | Categorical | | | 6 months ago | |
What will be Sunlenca's market share in HIV prevention drugs by end of 2024? | Categorical | | | 6 months ago | |
What will be lenacapavir's impact on global HIV infection rates by 2025? | Categorical | | | 10 days ago | |
How many countries will adopt generic lenacapavir by 2025? | Categorical | | | 10 days ago | |
What will be the adoption rate of lenacapavir in high-income countries by 2025? | Categorical | | | 10 days ago | |
Will Gilead announce a price reduction for lenacapavir in middle-income countries by 2025? | Binary | | | 10 days ago | |
Will lenacapavir be included in the WHO Essential Medicines list by 2025? | Binary | | | 10 days ago | |
Will Gilead reduce lenacapavir prices in middle-income countries by the end of 2025? | Binary | | | 11 days ago | |
How many countries will have approved generic versions of lenacapavir by the end of 2026? | Categorical | | | 11 days ago | |
What will be the reduction in new HIV infections due to lenacapavir by the end of 2026? | Categorical | | | 11 days ago | |
Which country will first approve lenacapavir for public use by the end of 2025? | Categorical | | | 11 days ago | |
Will lenacapavir be added to the WHO's list of essential medicines by the end of 2025? | Binary | | | 11 days ago | |
Will lenacapavir receive FDA approval for HIV prevention by the end of 2025? | Binary | | | 11 days ago | |
Will Gilead launch generic Lenacapavir in 120 countries by end of 2025? | Binary | | | 22 days ago | |
Which company will develop a similar biannual PrEP by end of 2025? | Categorical | | | 22 days ago | |
Which region will have the highest early adoption of Lenacapavir by end of 2025? | Categorical | | | 22 days ago | |
What will be the main barrier to Lenacapavir accessibility by end of 2025? | Categorical | | | 22 days ago | |
Will Lenacapavir be adopted as standard PrEP in 10 countries by end of 2025? | Binary | | | 22 days ago | |
Will WHO approve Lenacapavir for global use by June 30, 2025? | Binary | | | 22 days ago | |
WHO endorses new HIV prevention injections as standard treatment by end of 2025? | Binary | | | 22 days ago | |
Primary challenge in adoption of new HIV prevention injections by end of 2025? | Categorical | | | 22 days ago | |
Number of countries adopting Gilead's generic HIV prevention injections by end of 2025? | Categorical | | | 22 days ago | |
100% effectiveness of HIV prevention injections in women maintained by end of 2025? | Binary | | | 22 days ago | |
Will WHO include lenacapavir in essential medicines list by end of 2025? | Binary | | | 23 days ago | |
Will the US FDA approve lenacapavir for HIV prevention by end of 2025? | Binary | | | 23 days ago | |
Will major HIV/AIDS non-profits endorse lenacapavir by end of 2025? | Binary | | | 23 days ago | |
What will be Gilead's pricing strategy for lenacapavir by mid-2025? | Categorical | | | 23 days ago | |
What will be the adoption rate of lenacapavir compared to oral PrEP in US by end of 2025? | Categorical | | | 23 days ago | |
What will be the primary barrier to lenacapavir adoption in low-income countries by end of 2025? | Categorical | | | 23 days ago | |
Will Lenacapavir receive regulatory approval in South Africa by end of 2024? | Binary | | | 3 months ago | |
Will Lenacapavir receive regulatory approval in India by end of 2024? | Binary | | | 3 months ago | |
How many countries will grant regulatory approval for Lenacapavir by end of 2025? | Categorical | | | 3 months ago | |
Will a generic version of Lenacapavir be available in any country by mid-2025? | Binary | | | 3 months ago | |
Which country will first grant regulatory approval for Lenacapavir by end of 2024? | Categorical | | | 3 months ago | |
Which generic manufacturer will first produce Lenacapavir by mid-2025? | Categorical | | | 3 months ago | |
What will be the price range of Lenacapavir in its first year of launch? | Categorical | | | 3 months ago | |
How many regulatory approvals will Lenacapavir receive by the end of 2025? | Categorical | | | 3 months ago | |
What percentage of market share will Lenacapavir capture in the HIV prevention market by the end of 2025? | Categorical | | | 3 months ago | |
Will Gilead file for regulatory approval for Lenacapavir by the end of 2024? | Binary | | | 3 months ago | |
Will Lenacapavir receive regulatory approval in the US by mid-2025? | Binary | | | 3 months ago | |
What will be the revenue generated by Lenacapavir in its first full year of sales by end of 2025? | Categorical | | | 3 months ago | |
Will Gilead's Lenacapavir be included in WHO's list of essential medicines by end of September 2025? | Binary | | | 3 months ago | |
How many countries will approve Lenacapavir for HIV prevention by end of 2024? | Categorical | | | 3 months ago | |
What will be the market share of Lenacapavir compared to Truvada by end of 2025? | Categorical | | | 3 months ago | |
What market share will Livdelzi capture in the PBC treatment market by August 14, 2025? | Categorical | | | 4 months ago | |
How many new PBC patients will start treatment with Livdelzi by August 14, 2025? | Categorical | | | 4 months ago | |
Will Livdelzi receive full FDA approval for PBC by end of 2024? | Binary | | | 4 months ago | |
What will be Livdelzi's market share in PBC treatments by end of 2024? | Categorical | | | 4 months ago | |
How many countries will approve Livdelzi for PBC treatment by end of 2024? | Categorical | | | 4 months ago | |
What will be Gilead Sciences' next major acquisition by end of 2024? | Categorical | | | 4 months ago | |
What will be Gilead Sciences' total revenue for full-year 2024? | Categorical | | | 5 months ago | |
Which entity will secure the first large-scale procurement contract for lenacapavir by end of 2024? | Categorical | | | 6 months ago | |
Sunlenca global market adoption by mid-2025? | Categorical | | | 6 months ago | |
How many countries will approve Sunlenca for HIV prevention by end of 2024? | Categorical | | | 6 months ago | |
How many participants will be enrolled in post-approval studies of Sunlenca by end of 2024? | Categorical | | | 6 months ago | |
Percentage of global HIV infections prevented by new injections by end of 2025? | Categorical | | | 22 days ago | |
Which region will first adopt lenacapavir for HIV prevention by end of 2024? | Categorical | | | 6 months ago | |
Number of countries approving Sunlenca by end of 2024? | Categorical | | | 6 months ago | |